AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 11.31 |
Market Cap | 34.85M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -4.37 |
PE Ratio (ttm) | -3.05 |
Forward PE | n/a |
Analyst | Buy |
Ask | 21.82 |
Volume | 24,682 |
Avg. Volume (20D) | 30,273 |
Open | 13.46 |
Previous Close | 13.63 |
Day's Range | 13.20 - 13.63 |
52-Week Range | 7.38 - 30.99 |
Beta | undefined |
About VTVT
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is a...
Analyst Forecast
According to 1 analyst ratings, the average rating for VTVT stock is "Buy." The 12-month stock price forecast is $35, which is an increase of 162.37% from the latest price.
1 year ago · pennystocks.com
Best Penny Stocks To Buy Under $1? 4 To Watch NowFinding the best penny stocks to buy seems easy.